{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:10:04Z","timestamp":1780603804538,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008936","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000}}],"reference-count":145,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008936.pub2","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:15:50Z","timestamp":1663805750000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pharmacological interventions for the treatment of disordered and problem gambling"],"prefix":"10.1002","volume":"2022","author":[{"given":"Nicki","family":"Dowling","sequence":"additional","affiliation":[{"name":"School of Psychology; Deakin University; Geelong Australia"},{"name":"Melbourne Graduate School of Education; University of Melbourne; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Merkouris","sequence":"additional","affiliation":[{"name":"School of Psychology; Deakin University; Geelong Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lubman","sequence":"additional","affiliation":[{"name":"Turning Point; Eastern Health; Melbourne Australia"},{"name":"Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Thomas","sequence":"additional","affiliation":[{"name":"School of Health; Federation University; Melbourne Australia"},{"name":"Research School of Population Health; Australian National University; Melbourne Australia"},{"name":"Peking University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Bowden-Jones","sequence":"additional","affiliation":[{"name":"National Problem Gambling Clinic UK; Faculty of Brain Sciences, UCL; London UK"},{"name":"Department of Psychiatry; Cambridge University; Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Cowlishaw","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Melbourne; Melbourne Australia"},{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/15622975.2011.560964","article-title":"A double-blind, placebo controlled trial of topiramate for pathological gambling","volume":"14","author":"Berlin","year":"2013","journal-title":"World Journal of Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.jcp.0000264985.25109.25","article-title":"Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study","volume":"27","author":"Black","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling","volume":"14","author":"Blanco","year":"2002","journal-title":"Annals of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008936.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study","volume":"25","author":"Dannon","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study","volume":"28","author":"Dannon","year":"2005","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pbb.2007.12.025","article-title":"A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers","volume":"89","author":"Fong","year":"2008","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial","volume":"18","author":"Grant","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008936.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","article-title":"A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","volume":"69","author":"Grant","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","article-title":"Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study","volume":"197","author":"Grant","year":"2010","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling","volume":"47","author":"Hollander","year":"2000","journal-title":"Society of Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Society of Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008936.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling","volume":"63","author":"Kim","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v69n0314","article-title":"Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial","volume":"69","author":"McElroy","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/WNF.0b013e31828740ea","article-title":"Four-year follow-up study of pharmacological treatment in pathological gamblers","volume":"36","author":"Rosenberg","year":"2013","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4088\/JCP.v66n0104","article-title":"Sertraline treatment of pathological gambling: a pilot study","volume":"66","author":"Saiz-Ruiz","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0018|cit18","first-page":"65A","article-title":"Treating gambling disorder with fast acting opioid antagonist-naltrexone nasal spray: a novel feasibility study","volume":"42","author":"Alho","year":"2018","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"107127","DOI":"10.1016\/j.addbeh.2021.107127","article-title":"Intranasal as needed naloxone in the treatment of gambling disorder: a randomised controlled trial","volume":"125","author":"Alho","year":"2022","journal-title":"Addictive Behaviors"},{"issue":"33","key":"10.1002\/14651858.CD008936.pub2-BIB0020|cit20","first-page":"1","article-title":"Acamprosate and baclofen were not effective in the treatment of pathological gambling: preliminary blind rater comparison study","volume":"2","author":"Dannon","year":"2011","journal-title":"Front Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.brat.2011.08.009","article-title":"Cognitive-behavioural treatment of pathological gambling in individuals with chronic schizophrenia: a pilot study","volume":"49","author":"Echeburua","year":"2011","journal-title":"Behaviour Research and Therapy"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","article-title":"Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation","volume":"21","author":"Grant","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.13m08411","article-title":"A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers","volume":"75","author":"Grant","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008936.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.4088\/JCP.16m11220","article-title":"Naltrexone and disulfiram treatment response in veterans with alcohol dependence and co-occurring problem-gambling features","volume":"78","author":"Grant","year":"2017","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000435876","article-title":"A randomised, double-blind, placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling","volume":"22","author":"Kovanen","year":"2016","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/FBP.0b013e32835f3cff","article-title":"The influence of acutely administered nicotine on cue-induced craving for gambling in at-risk video lottery terminal gamblers who smoke","volume":"24","author":"McGrath","year":"2013","journal-title":"Behavioural Pharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/14459795.2011.559647","article-title":"A pilot study of CBT versus escitalopram combined with CBT in the treatment of pathological gamblers","volume":"11","author":"Myrseth","year":"2011","journal-title":"International Gambling Studies"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0029|cit29","unstructured":"Effectiveness of sertraline in treating pathological gamblers with a diagnosis of alcohol dependence clinicaltrials.gov\/ct2\/show\/NCT00249431"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0030|cit30","unstructured":"Naltrexone in the treatment of concurrent alcohol dependence and pathological gambling clinicaltrials.gov\/ct2\/show\/NCT00326807"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0031|cit31","unstructured":"N-acetyl cysteine plus behavioral therapy for nicotine dependent pathological gamblers clinicaltrials.gov\/ct2\/show\/NCT00967005"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0032|cit32","unstructured":"Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention clinicaltrials.gov\/ct2\/show\/NCT01528007"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0033|cit33","unstructured":"Topiramate trial for pathological gamblers clinicaltrials.gov\/ct2\/show\/NCT01843699"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0034|cit34","unstructured":"Treatment of gambling disorder with fast acting opiate antagonist, naloxone nasal spray (NALPILO) clinicaltrials.gov\/ct2\/show\/NCT03223896"},{"issue":"7","key":"10.1002\/14651858.CD008936.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","article-title":"Lithium and valproate treatment of pathological gambling: a randomized single-blind study","volume":"63","author":"Pallanti","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD008936.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/0269881109106907","article-title":"Serotonin function in pathological gambling: blunted growth hormone response to Sumatriptan","volume":"24","author":"Pallanti","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnbeh.2013.00138","article-title":"Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers","volume":"7","author":"Porchet","year":"2013","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0038|cit38","first-page":"133","article-title":"Problem-gambling features are associated with poorer treatment outcome among dually diagnosed US military veterans with alcohol dependence","volume":"7","author":"Potenza","year":"2018","journal-title":"Journal of Behavioral Addictions"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0039|cit39","first-page":"1","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"67","author":"Thomas","year":"2010","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10550490902787007","article-title":"A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling","volume":"18","author":"Toneatto","year":"2009","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0041|cit41","unstructured":"Investigation of naltrexone for pathological gambling clinicaltrials.gov\/ct2\/show\/NCT01057862"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0042|cit42","unstructured":"Randomised controlled trial for gambling and naltrexone, using eye-tracking analysis to predict treatment response clinicaltrials.gov\/ct2\/show\/study\/NCT04738773"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0043|cit43","unstructured":"Milk thistle in pathological gambling clinicaltrials.gov\/ct2\/show\/NCT02337634"},{"issue":"14","key":"10.1002\/14651858.CD008936.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2174\/138161211796150774","article-title":"Psychopharmacological treatment in pathological gambling: a critical review","volume":"17","author":"Achab","year":"2011","journal-title":"Current Pharmaceutical Design"},{"issue":"5","key":"10.1002\/14651858.CD008936.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1360-0443.2008.02414.x","article-title":"A question of balance: prioritizing public health responses to harm from gambling","volume":"104","author":"Adams","year":"2009","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0046|cit46","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/1516-4446-2013-1244","article-title":"Systematic review of N-acetylcysteine in the treatment of addictions","volume":"36","author":"Asevedo","year":"2014","journal-title":"Brazilian Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD008936.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1586\/14737175.2013.814938","article-title":"Meta-analysis: pharmacological treatment of pathological gambling","volume":"13","author":"Bartley","year":"2013","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/22115560113029990008","article-title":"Update on the pharmacological treatment of pathological gambling","volume":"2","author":"Bullock","year":"2013","journal-title":"Current Psychopharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"Double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1556\/2006.5.2016.073","article-title":"Problem gambling worldwide: an update and systematic review of empirical research (2000-2015)","volume":"5","author":"Calado","year":"2016","journal-title":"Journal of Behavioral Addictions"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hup.990","article-title":"Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials","volume":"24","author":"Ceron-Litvoc","year":"2009","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/14459795.2018.1470662","article-title":"A review of opioid-based treatments for gambling disorder: an examination of treatment outcomes, cravings, and individual difference","volume":"18","author":"Christensen","year":"2018","journal-title":"International Gambling Studies"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychological Bulletin"},{"issue":"11","key":"10.1002\/14651858.CD008936.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008937.pub2","article-title":"Psychological therapies for pathological and problem gambling","author":"Cowlishaw","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12954-017-0131-8","article-title":"The influence of marketing on the sports betting attitudes and consumption behaviours of young men: implications for harm reduction and prevention strategies","volume":"14","author":"Deans","year":"2017","journal-title":"Harm Reduction Journal"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0057|cit57","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008 Available from training.cochrane.org\/handbook\/archive\/v5.0.0\/"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0081246314522367","article-title":"Criterion-related and construct validity of the Problem Gambling Severity Index in a sample of South African gamblers","volume":"44","author":"Dellis","year":"2014","journal-title":"South African Journal of Psychology"},{"issue":"8","key":"10.1002\/14651858.CD008936.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.addbeh.2014.04.011","article-title":"The impacts of problem gambling on concerned significant others accessing web-based counselling","volume":"39","author":"Dowling","year":"2014","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.addbeh.2014.07.006","article-title":"Problem gambling and family violence: prevalence and patterns in help-seeking populations","volume":"39","author":"Dowling","year":"2014","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0004867415575774","article-title":"Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: a systematic review and meta-analysis","volume":"49","author":"Dowling","year":"2015","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1521\/pedi_2014_28_168","article-title":"The prevalence of comorbid personality disorders in treatment-seeking problem gamblers: a systematic review and meta-analysis","volume":"29","author":"Dowling","year":"2015","journal-title":"Journal of Personality Disorders"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1524838014561269","article-title":"Problem gambling and intimate partner violence: a systematic review and meta-analysis","volume":"17","author":"Dowling","year":"2016","journal-title":"Trauma, Violence, and Abuse"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.addbeh.2016.02.012","article-title":"Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research","volume":"58","author":"Dowling","year":"2016","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cpr.2016.10.008","article-title":"Early risk and protective factors for problem gambling: a systematic review and meta-analysis of longitudinal studies","volume":"51","author":"Dowling","year":"2017","journal-title":"Clinical Psychological Review"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1556\/2006.7.2018.74","article-title":"Problem gambling and family violence: findings from a population-representative study","volume":"7","author":"Dowling","year":"2018","journal-title":"Journal of Behavioral Addictions"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0068|cit68","unstructured":"Ferris J Wynne HJ The Canadian Problem Gambling Index: Final Report www.greo.ca\/Modules\/EvidenceCentre\/Details\/canadian-problem-gambling-index-final-report"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1590\/1516-4446-2016-1911","article-title":"Development and validation of the Gambling Follow-up Scale, Self-Report version: an outcome measure in the treatment of pathological gambling","volume":"39","author":"Galetti","year":"2017","journal-title":"Brazilian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0070|cit70","unstructured":"Gernstein D Voldberg RA Toce MT Harwood H Johnson RA Buie T Gambling impact and behavior study: report to the National Gambling Impact Study Commission www.norc.org\/PDFs\/publications\/GIBSFinalReportApril1999.pdf"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/14656566.8.1.13","article-title":"Bipolar depression: a review of randomised controlled trials","volume":"8","author":"Goodnick","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10899-018-09815-y","article-title":"Pharmacological treatments for disordered gambling","volume":"35","author":"Goslar","year":"2019","journal-title":"Journal of Gambling Studies"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psychres.2004.05.006","article-title":"Preliminary validity and reliability testing of a structured clinical interview for pathological gambling","volume":"128","author":"Grant","year":"2004","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2125.2012.04457.x","article-title":"Pharmacological treatments in pathological gambling","volume":"77","author":"Grant","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"25","key":"10.1002\/14651858.CD008936.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.2174\/13816128113199990626","article-title":"The genetics of problem and pathological gambling: a systematic review","volume":"20","author":"Gyollai","year":"2014","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.comppsych.2015.01.003","article-title":"Prevalence and correlates of problem gambling in people with psychotic disorders","volume":"58","author":"Haydock","year":"2015","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/ejn.13396","article-title":"Pathological gambling in Parkinson's disease: what are the risk factors and what is the role of impulsivity?","volume":"45","author":"Heiden","year":"2017","journal-title":"European Journal of Neuroscience"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0080|cit80","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008 Available from training.cochrane.org\/handbook\/archive\/v5.0.0\/"},{"issue":"29","key":"10.1002\/14651858.CD008936.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0082|cit82","unstructured":"Higgins JP Deeks JJ Altman DR Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008 Available from training.cochrane.org\/handbook\/archive\/v5.0.0\/"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0084|cit84","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0085|cit85","unstructured":"Hing N O'Mullan C Nuske E Breen H Mainey L Taylor A Gambling-related intimate partner violence against women: a grounded theory model of individual and relationship determinants Journal of Interpersonal Violence 10.1177\/08862605211037425"},{"issue":"12","key":"10.1002\/14651858.CD008936.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1176\/ajp.155.12.1781","article-title":"Short-term single-blinded fluvoxamine treatment of pathological gambling","volume":"155","author":"Hollander","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychological Methods"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0088|cit88","doi-asserted-by":"crossref","DOI":"10.4135\/9781412985031","volume-title":"Methods of Meta-Analysis: Correcting Error and Bias in Research Findings","author":"Hunter","year":"2004"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1192\/bjp.bp.114.154286","article-title":"Gambling problems in bipolar disorder in the UK: prevalence and distribution","volume":"207","author":"Jones","year":"2015","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","article-title":"The hazards of scoring the quality of clinical trials for meta-analysis","volume":"282","author":"Juni","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mpr.168","article-title":"The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)","volume":"13","author":"Kessler","year":"2004","journal-title":"International Journal of Methods in Psychiatric Research"},{"issue":"11","key":"10.1002\/14651858.CD008936.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.008","article-title":"The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study","volume":"166","author":"Kim","year":"2009","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/bjaed\/mkw060","article-title":"Patient-reported outcome measures and patient-reported experience measures","volume":"17","author":"Kingsley","year":"2017","journal-title":"BJA Education"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1023005115932","article-title":"Gambling and the health of the public: adopting a public health perspective","volume":"15","author":"Korn","year":"1999","journal-title":"Journal of Gambling Studies"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1023685416816","article-title":"Framing public policy towards a public health paradigm for gambling","volume":"19","author":"Korn","year":"2003","journal-title":"Journal of Gambling Studies"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"70\u20139","DOI":"10.1159\/000435876","article-title":"A randomised, double-blind, placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling","volume":"22","author":"Kovanen","year":"2016","journal-title":"European Addiction Research"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/14656566.2019.1702969","article-title":"Current pharmacotherapy for gambling disorder: a systematic review","volume":"21","author":"Kraus","year":"2020","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD008936.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pharep.2014.05.003","article-title":"The latest achievements in the pharmacotherapy of gambling disorder","volume":"66","author":"Labuzek","year":"2014","journal-title":"Pharmacological Reports"},{"issue":"16","key":"10.1002\/14651858.CD008936.pub2-BIB0100|cit100","first-page":"80","article-title":"Understanding gambling related harm: a proposed definition, conceptual framework, and taxonomy of harms","volume":"1","author":"Langham","year":"2016","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1002\/14651858.CD008936.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.144.9.1184","article-title":"The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers","volume":"144","author":"Lesieur","year":"1987","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YCO.0b013e32831575d9","article-title":"Treatment of pathological gambling","volume":"22","author":"Leung","year":"2009","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1360-0443.2010.03300.x","article-title":"Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys","volume":"106","author":"Lorains","year":"2011","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/537306","article-title":"Pharmacological treatments in gambling disorder: a qualitative review","volume":"2014","author":"Lupi","year":"2014","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0284-8","article-title":"Women and gambling-related harm: a narrative literature review and implications for research, policy, and practice","volume":"16","author":"McCarthy","year":"2019","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1399-5618.2002.01189.x","article-title":"Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study","volume":"4","author":"McIntyre","year":"2002","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.pra.0000333583.75741.8b","article-title":"Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review","volume":"14","author":"Melvin","year":"2008","journal-title":"Journal of Psychiatric Practice"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s40429-016-0106-y","article-title":"An update on gender differences in the characteristics associated with problem gambling: a systematic review","volume":"3","author":"Merkouris","year":"2016","journal-title":"Current Addiction Reports"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000480539","article-title":"Naltrexone in the treatment of broadly defined behavioral addictions: a review and meta-analysis of randomized controlled trials","volume":"23","author":"Mouaffak","year":"2017","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pnpbp.2011.01.016","article-title":"Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial","volume":"35","author":"Mowla","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/14459795.2011.559647","article-title":"A pilot study of CBT versus escitalopram combined with CBT in the treatment of pathological gamblers","volume":"11","author":"Myserth","year":"2011","journal-title":"International Gambling Stusiea"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0114|cit114","unstructured":"Neal P Delfabbro P O'Neil M Problem gambling and harm: toward a national definition www.gamblingresearch.org.au\/publications\/problem-gambling-and-harm-towards-national-definition"},{"issue":"14","key":"10.1002\/14651858.CD008936.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1080\/03610926.2015.1134575","article-title":"Relative effect sizes for measures of risk","volume":"46","author":"Oliver","year":"2017","journal-title":"Communications in Statistics - Theory and Methods"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","article-title":"Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)","volume":"21","author":"Pallanti","year":"2005","journal-title":"Journal of Gambling Studies"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/jcp.013e3180dcc304d","article-title":"Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis","volume":"27","author":"Pallesen","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"Article ID 1097","DOI":"10.1155\/2014\/109786","article-title":"Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives","author":"Pettorruso","year":"2014","journal-title":"BioMed Research International"},{"issue":"9","key":"10.1002\/14651858.CD008936.pub2-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003384.pub3","article-title":"Topiramate for acute affective episodes in bipolar disorder in adults","author":"Pigott","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.conb.2013.03.004","article-title":"Neurobiology of gambling behaviours","volume":"23","author":"Potenza","year":"2013","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0121|cit121","unstructured":"Queensland Government Statistician's Office Australian Gambling Statistics 36th edition www.qgso.qld.gov.au\/issues\/2646\/australian-gambling-statistics-36th-edn-1993-94-2018-19.pdf"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0122|cit122","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ajad.12656","article-title":"Gambling and interpersonal violence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"27","author":"Roberts","year":"2018","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10896-019-00045-3","article-title":"Intimate partner violence in treatment seeking problem gamblers","volume":"35","author":"Roberts","year":"2020","journal-title":"Journal of Family Violence"},{"issue":"9306","key":"10.1002\/14651858.CD008936.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-4505-4-21","article-title":"Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations","volume":"4","author":"Schunemann","year":"2006","journal-title":"Health Research Policy and Systems"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0127|cit127","volume-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","author":"Sobell","year":"1992"},{"issue":"2","key":"10.1002\/14651858.CD008936.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1037\/0893-164X.21.2.174","article-title":"Development and psychometric evaluation of the gambling treatment outcome monitoring system (GAMTOMS)","volume":"21","author":"Stinchfield","year":"2007","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0130|cit130","unstructured":"The world's biggest gamblers www.economist.com\/graphic-detail\/2017\/02\/09\/the-worlds-biggest-gamblers"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"664","DOI":"10.5694\/mja11.11088","article-title":"Australian guideline for treatment of problem gambling: an abridged outline","volume":"195","author":"Thomas","year":"2011","journal-title":"Medical Journal of Australia"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0376-8716(93)90042-O","article-title":"The development of a cocaine craving questionnaire","volume":"34","author":"Tiffany","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10550490902787007","article-title":"A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling","volume":"18","author":"Toneatto","year":"2009","journal-title":"American Journal of Addiction"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1874473711205010003","article-title":"Evidence-based pharmacological treatment of substance use disorders and pathological gambling","volume":"5","author":"Van den Brink","year":"2012","journal-title":"Current Drug Abuse Reviews"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0135|cit135","first-page":"22","article-title":"Treatment of gambling disorder: a systematic review of current evidence","volume":"2","author":"Vasiliu","year":"2017","journal-title":"International Journal of Psychiatry and Psychotherapy"},{"issue":"10","key":"10.1002\/14651858.CD008936.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1570159X15666170718144058","article-title":"Opioid antagonists for pharmacological treatment of gambling disorder: are they relevant","volume":"16","author":"Victorri-Vigneau","year":"2018","journal-title":"Current Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD008936.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1360-0443.2005.01341.x","article-title":"A framework for reporting outcomes in problem gambling treatment research: The Banff, Alberta Consensus","volume":"101","author":"Walker","year":"2006","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD008936.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1556\/2006.7.2018.89","article-title":"The use of naltrexone in pathological and problem gambling","volume":"7","author":"Ward","year":"2018","journal-title":"Journal of Behavioral Addictions"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11469-006-9038-4","article-title":"Are the effects of gambling treatment overestimated?","volume":"5","author":"Westphal","year":"2007","journal-title":"International Journal of Mental Health and Addiction"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0140|cit140","volume-title":"International Classification of Diseases for Mortality and Morbidity Statistics","author":"World Health Organization","year":"2018"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0141|cit141","unstructured":"Williams RJ Voldberg RA Stevens RM The population prevalence of problem gambling: methodological influences, standardized rates, jurisdictional differences, and worldwide trends www.greo.ca\/Modules\/EvidenceCentre\/Details\/population-prevalence-problem-gambling-methodological-influences-standardized-rates-0"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14459795.2013.839731","article-title":"The classification accuracy of four problem gambling assessment instruments in population research","volume":"14","author":"Williams","year":"2014","journal-title":"International Gambling Studies"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0143|cit143","first-page":"143","volume-title":"The Downside: Problem and Pathological Gambling","author":"Winters","year":"2002"},{"key":"10.1002\/14651858.CD008936.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3389\/fpsyg.2017.02121","article-title":"Genetic and environmental influences on gambling: a meta-analysis of twin studies","volume":"8","author":"Xuan","year":"2017","journal-title":"Frontiers in Psychology"},{"issue":"1","key":"10.1002\/14651858.CD008936.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008936","article-title":"Pharmacological interventions for the treatment of pathological and problem gambling","author":"Anderson","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T14:24:20Z","timestamp":1719671060000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008936.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":145,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008936.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]}}}